+486.8%
INSM vs THC
+319.5%
+167.2%
-56.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +20.6% | -2.9% | +23.4% | +20.9% |
| 7D | +22.4% | -8.1% | +30.5% | +23.5% |
| 30D | +51.0% | -3.2% | +54.2% | +51.5% |
| 3M | +10.6% | -1.8% | +12.4% | +10.7% |
| 6M | +34.5% | +37.7% | -3.2% | +28.1% |
| YTD | -17.0% | +32.6% | -49.6% | -20.7% |
| 1Y | -29.0% | +35.7% | -64.7% | -32.4% |
| All | +486.8% | +319.5% | +167.2% | +312.9% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling